Last reviewed · How we verify

NCT06565481: HEMOPRO

Measurement Properties in People with Hemophilia

Recruiting now NA Last updated 14 January 2025
What this trial tests

NA trial testing Measurement Properties (Reliability and Validity) of a Set of Assessments evaluating Physical Function in adult Participants with Hemophilia in Hemophilia a in 50 participants. Currently enrolling.

Timeline
31 October 2024
Primary endpoint
31 May 2026
31 May 2026

Quick facts

Lead sponsorUniversity of Zurich
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment50
Start date31 October 2024
Primary completion31 May 2026
Estimated completion31 May 2026
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

University of Zurich

Who can join

18 and older, any sex, with Hemophilia a or Hemophilia B. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this project is to determine the measurement properties (namely reliability and validity) of a set of clinical assessments, measuring different aspects of physical function.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hemophilia a

Currently open trials in the same condition.

Other University of Zurich trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06565481.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing